logo
February 6 - 9, 2020 | Orlando

Jim DeMesa, MD, MBA

speaker photo CANNABIS INVESTMENTS

Chief Executive Officer

Emerald Health Pharmaceuticals Inc.

Dr. Jim DeMesa is a former practicing physician and has 29 years of experience in biotech leadership, product development, clinical and regulatory management, and partnerships with pharmaceutical, biotech, and medical device companies. He has led the advancement of product development from preclinical to clinical development, regulatory approval, and commercialization. Dr. DeMesa is the former CEO of two public biotech companies and currently serves as director for two biotech companies. He received BA in chemistry, M.D., and M.B.A. degrees from the University of South Florida.

Speaker Schedule

The Scientific and Investment Potential of Cannabinoids
February 9, 2019, 8:00 am - 8:45 am EST

Focus: CANNABIS INVESTMENTS